Same-day discharge (SDD) is an effective treatment option for patients undergoing atrial fibrillation (AFib) ablation, according to new findings presented at Heart Rhythm 2022. …

The U.S. Food and Drug Administration (FDA) has approved mavacamten, sold by Bristol Myers Squibb (BMS) under the name Camzyos, for the treatment of adult patients…

Same-day discharge (SDD) after left atrial appendage occlusion (LAAO) is a safe treatment option that does not lead to worse patient outcomes, according to new findings published in the American Journal of Cardiology.[1]…

Using drones to deliver automated external defibrillators (AEDs) is an effective way to reach patients suffering from out-of-hospital cardiac arrest (OHCA), according to a new analysis published in European Heart Journal.[1…

Fitbit’s new algorithm for identifying signs of atrial fibrillation (AFib) has been cleared by the FDA.

The photoplethysmography (PPG) algorithm was designed to passively evaluate a user’s heart…

Among patients who received a smartwatch notification that they may have atrial fibrillation (AFib), 94% of those who followed up with a doctor were confirmed to indeed have the common…

The U.S. Food and Drug Administration (FDA) has approved Abbott’s Aveir single-chamber (VR) leadless pacemaker as a treatment option for patients with slow heart rhythms. It is the second VR leadless pacemaker to gain approval in the…

Patients with atrial fibrillation (AFib) may be able to reduce their risk of developing dementia by taking direct-acting oral anticoagulants (DOACs) instead of warfarin, according to a new study published in the Journal of the…

Older left atrial appendage occlusion (LAAO) patients may face a higher risk of in-hospital mortality or procedure-related complications, according to new research published in the American Journal of Cardiology.[1]…

Bariatric surgery can help obese patients lower their risk of all-cause and cardiovascular mortality, according to a new systematic review and meta-analysis published in European Heart Journal.[1]

…

The American College of Cardiology (ACC) has issued a new expert consensus decision pathway for the evaluation and management of adults with cardiovascular consequences stemming from a…

An advanced artificial intelligence (AI) algorithm examining electrocardiograms (ECG) can help clinicians diagnose and treat hypertrophic cardiomyopathy (HCM), according to a new study published in the Journal of the American…

ACC.22, the annual meeting of the American College of Cardiology, isn’t the only industry conference taking place in early April: EHRA 2022, the yearly get-together hosted by the…

Screening older patients for atrial fibrillation (AFib) during primary care visits provides little value, according to new research published in Circulation.[1]

The study’s authors noted that…

Direct oral anticoagulants (DOACs) may be an effective anticoagulation strategy for atrial fibrillation (AFib) patients who undergo bioprosthetic valve replacement, according to a new meta-analysis published in the American…

Cardiac resynchronization therapy with a defibrillator (CRT-D) is associated with “significant improvements” in mortality and heart failure (HF) hospitalization…

The University of California San Diego Health has debuted a new technology that may offer a better way to assess and treat…

Medtronic has gained an expanded FDA approval for its Freezor and…